Cipher Pharmaceuticals Inc. (CPH)

Cipher Pharmaceuticals Inc. (CPH $15.11)
- $15.11 P/E (TTM): 15.33X Cap: $383M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Cipher Pharmaceuticals Inc. (CPH $15.11)
- $15.11 P/E (TTM): 15.33X Cap: $383M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Firan Technology Group Corporation (FTG $11.12)
- $11.12 P/E (TTM): 24.07X Cap: $279M
- View FTG Profile
- View Questions on FTG
Stingray Group Inc. Subordinate Voting Shares (RAY.A $15.23)
- $15.23 P/E (TTM): 19.73X Cap: $1.03B
- View RAY.A Profile
- View Questions on RAY.A
HIVE Digital Technologies Ltd. (HIVE $4.68)
- $4.68 P/E (TTM): 26.87X Cap: $1.11B
- View HIVE Profile
- View Questions on HIVE
Zoomd Technologies Ltd. (ZOMD $1.91)
- $1.91 P/E (TTM): 8.92X Cap: $192M
- View ZOMD Profile
- View Questions on ZOMD
Telesat Corporation Common and Variable Voting Shares (TSAT $35.58)
- $35.58 Cap: $1.28B
- View TSAT Profile
- View Questions on TSAT

Q: Your portfolio manager(s) on the Growth portfolio have been very active lately. I own a lot of the growth but a bunch of new names have come up and I don't have room for all of them

Can you please prioritize of those names listed above which ones offer the best growth over the next 5 years.

Can you please list in order of highest to lowest conviction.

Thanks

Sheldon

Read Answer Asked by Sheldon on November 25, 2025

Knight Therapeutics Inc. (GUD $6.07)
- $6.07 Cap: $605M
- View GUD Profile
- View Questions on GUD
- View Reports on GUD
Savaria Corporation (SIS $21.57)
- $21.57 P/E (TTM): 25.02X Cap: $1.54B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS
Cipher Pharmaceuticals Inc. (CPH $15.11)
- $15.11 P/E (TTM): 15.33X Cap: $383M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Vitalhub Corp. (VHI $9.33)
- $9.33 P/E (TTM): 180.2X Cap: $588M
- View VHI Profile
- View Questions on VHI
- View Reports on VHI
WELL Health Technologies Corp. (WELL $3.88)
- $3.88 Cap: $967M
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
DRI Healthcare Trust (DHT.UN $16.81)
- $16.81 Cap: $927M
- View DHT.UN Profile
- View Questions on DHT.UN
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.92)
- $0.92 Cap: $284M
- View AIDX Profile
- View Questions on AIDX

Q: how do you rank them to buy now 1 to 10 after the q3 reported. thanks

Read Answer Asked by c c on November 09, 2025

Cipher Pharmaceuticals Inc. (CPH $15.11)
- $15.11 P/E (TTM): 15.33X Cap: $383M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH

Q: What did u think of their last quarter in light of the stock drop? Thank u

Read Answer Asked by John on November 10, 2025

Review of Cipher Pharmaceuticals

{tplLang.details | toLang tLang}

{tplLang.industryclassifications | toLang tLang}

{tplLang.toolname| toLang tLang}